Other than as provided in 180 NAC 7-026, the licensee must
require an authorized user for the oral administration of sodium iodide 1-131
in quantities greater than 1.22 GBq (33 mCi), to be a physician who:
(A) Is certified by a medical specialty board
whose certification process includes all of the requirements in 180 NAC
7-053(C)(i) and (ii) and whose certification has been recognized the
Department, an Agreement State or the NRC. The name of board certifications
that have been recognized by an Agreement State or the NRC are posted on the
NRC's Medical Uses Licensee Toolkit website; or
(B) Is an authorized user under 180 NAC
7-051, for uses listed in 180 NAC 7-051(B)(i)(2)(f)(ii), or equivalent
Agreement State, or NRC requirements; or
(C) The physician has:
(i) Successfully completed 80 hours of
classroom and laboratory training, applicable to the medical use of sodium
iodide I-131 for procedures requiring a written directive; the training must
include:
(1) Radiation physics and
instrumentation;
(2) Radiation
protection;
(3) Mathematics
pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for
medical use; and
(5) Radiation
biology;
(ii) Work
experience, under the supervision of an authorized user who meets the
requirements in 180 NAC 7-026, 7-051, 7-053, or equivalent NRC or Agreement
State requirements. A supervising authorized user, who meets the requirements
in 180 NAC 7-051(B), must have experience in administering dosages as specified
in 180 NAC 7-051(B)(i)(2)(f)(ii). Work experience must involve:
(1) Ordering, receiving, and unpacking
radioactive materials safely and performing the related radiation
surveys;
(2) Performing quality
control procedures on instruments used to determine the activity of dosages and
performing checks for proper operation of survey meters;
(3) Calculating, measuring, and safely
preparing patient or human research subject dosages;
(4) Using administrative controls to prevent
a misadministration event involving the use of radioactive material;
(5) Using procedures to contain spilled
radioactive material safely and using proper decontamination procedures;
and
(6) Administering dosages to
patients or human research subjects, that includes at least three cases
involving the oral administration of greater than 1.22 GBq (33 mCi) of sodium
iodide I-131; and
(iii)
Obtained written attestation that the individual has satisfactorily completed
the requirements in paragraphs 180 NAC 7-053(C)(i) and (ii), and is able to
independently fulfill the radiation safety-related duties as an authorized user
for oral administration of greater than 1.22 gigabecquerels (33 millicuries) of
sodium iodide I-131 for medical uses authorized under 180 NAC 7-048. The
attestation must be obtained from either:
(1)
A preceptor authorized user who meets the requirements in 7-026, 7-051, 7-053,
equivalent NRC or Agreement State requirements, and has experience in
administering dosages as specified in 7-051(B)(i)(2)(f)(ii); or
(2) A residency program director who affirms
in writing that the attestation represents the consensus of the residency
program faculty where at least one faculty member is an authorized user who
meets the requirements in 7-026, 7-051, 7-053, equivalent NRC or Agreement
State requirements, has experience in administering dosages as specified in
7-051(B)(i)(2)(f)(ii), and concurs with the attestation provided by the
residency program director. The residency training program must be approved by
the Residency Review Committee of the Accreditation Council for Graduate
Medical Education or the Royal College of Physicians and Surgeons of Canada or
the Council on Postdoctoral Training of the American Osteopathic Association
and must include training and experience specified in 7-053(C)(i) and
(i).